Principais notícias

Ações

Can OKYO Pharma Give Doctors Their First Answer to Neuropathic Corneal Pain?

London-based OKYO Pharma has enrolled the first patients in a Phase 3 trial for a painful eye condition with no FDA-approved treatment. The start is real. The answer is still a trial away.

Cabot Square, Canary Wharf June 2008

Mais notícias de Reino Unido

Explicações do Mercado Britânico